{
    "applicationNumber": "BR 11 2021 001613-9",
    "filingDate": "12/08/2019",
    "grantDate": null,
    "title": "AGENTES DE \u00c1CIDO RIBONUCLEICO DE FITA DUPLA, C\u00c9LULA, COMPOSI\u00c7\u00d5ES FARMAC\u00caUTICAS, M\u00c9TODOS DE INIBI\u00c7\u00c3O DA EXPRESS\u00c3O G\u00caNICA, DE INIBI\u00c7\u00c3O DA REPLICA\u00c7\u00c3O E DE TRATAR UM SUJEITO, M\u00c9TODOS PARA REDUZIR O N\u00cdVEL DE UM ANT\u00cdGENO E PARA REDUZIR A CARGA VIRAL E USO DE UM AGENTE DE DSRNA",
    "nationalPhaseDate": [
        "28/01/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2019/046142",
        "pctDate": "12/08/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/718,314",
            "priorityDate": "13/08/2018"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2614"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2626"
        }
    ],
    "inventors": [
        "VASANT R JADHAV",
        "MARTIN A MAIER",
        "STUART MILSTEIN",
        "MARK K SCHLEGEL"
    ],
    "holders": [
        79595
    ],
    "ipcCodes": [
        "C12N 15/113",
        "A61P 31/20",
        "A61K 31/713"
    ]
}